Study number 8528-250
Dates
Nov 03 2024-Nov 18 2024
Location
Dallas, Texas
Age
18-65
Gender
Compensation
$5,280
Group
B3
The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of the study drug gradually increasing dose levels. The study will also measure how much of the study drug gets into the bloodstream, urine, and cerebrospinal fluid (lumbar puncture groups only) and how long it takes the body to get rid of it. This is the first time that the study drug will be given to humans.
Fortrea Dallas, Tx is recruiting for:
-Healthy Non-Smoking Adults, age 18-65
-Body Mass Index between 18-32
-Study involves 1 stay of 13 night & 1 follow-up visit
-Compensation up to $5,280 may be provided for time and participation
-Refer a friend to receive $300 per qualified referral
B3:
Check-in: Nov 3
Check-out: Nov 16
OPV: Nov 18